Docetaxel and gemcitabine combinations in non-small cell lung cancer

Seminars in Oncology

Volumn 26, Issue 5 SUPPL. 16, 1999, Pages 27-31

  Rizvi, N A ^a   Spiridonidis, C H ^a   Davis, T H ^a   Bhargava, P ^a   Marshall, J L ^a   Dahut, W ^a   Figuera, M ^a   Hawkins, M J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GEMCITABINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DIARRHEA; DRUG TOLERABILITY; FATIGUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; PACLITAXEL; TAXOIDS;

EID: 0032723312     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)